{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T03:57:03Z","timestamp":1771991823130,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiological Methods"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.mimet.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T19:39:05Z","timestamp":1546976345000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Comparison of Neisseria gonorrhoeae minimum inhibitory concentrations obtained using agar dilution versus microbroth dilution methods"],"prefix":"10.1016","volume":"157","author":[{"given":"Rachael K.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marysa J.","family":"Notaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant J.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mimet.2019.01.001_bb0015","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1128\/jcm.34.12.3214-3217.1996","article-title":"Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: Investigation using 510(k) review criteria, recommended by the food and drug administration","volume":"34","author":"Biedenbach","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mimet.2019.01.001_bb0020","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1128\/jcm.32.7.1825-1826.1994","article-title":"Improved enrichment broth for cultivation of fastidious organisms","volume":"32","author":"Cartwright","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mimet.2019.01.001_bb0025","unstructured":"CDC and FDA Antibiotic Resistance Isolate Bank. Atlanta (GA): CDC. [August 7, 2018] 2018."},{"key":"10.1016\/j.mimet.2019.01.001_bb0030","series-title":"Neisseria Gonorrhoeae Reference Strains for Antimicrobial Susceptibility Testing","author":"Centers for Disease Control and Prevention (CDC)","year":"2005"},{"key":"10.1016\/j.mimet.2019.01.001_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.annemergmed.2012.10.014","article-title":"Update to the CDC's sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.mimet.2019.01.001_bb0040","series-title":"Gonococcal Isolate Surveillance Project (GISP)","first-page":"1","author":"Centers for Disease Control and Prevention (CDC)","year":"2013"},{"key":"10.1016\/j.mimet.2019.01.001_bb0045","series-title":"Gonococcal Isolate Surveillance Project (GISP) Protocol","author":"Centers for Disease Control and Prevention (CDC)","year":"2015"},{"key":"10.1016\/j.mimet.2019.01.001_bb0050","series-title":"Sexually Transmitted Disease Surveillance 2013: Gonococcal Isolate Surveillance Project (GISP)","author":"Centers for Disease Control and Prevention (CDC)","year":"2015"},{"key":"10.1016\/j.mimet.2019.01.001_bb0055","series-title":"Combating the Threat of Antibiotic-Resistant Gonorrhea","first-page":"1","author":"Centers for Disease Control and Prevention (CDC)","year":"2017"},{"key":"10.1016\/j.mimet.2019.01.001_bb0060","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","author":"CLSI","year":"2015"},{"key":"10.1016\/j.mimet.2019.01.001_bb0065","series-title":"M100S: Performance Standards for Antimicrobial Susceptibility Testing","author":"CLSI","year":"2016"},{"key":"10.1016\/j.mimet.2019.01.001_bb0070","series-title":"CLSI Supplement M100","article-title":"Performance standards for antimicrobial susceptibility testing","year":"2017"},{"key":"10.1016\/j.mimet.2019.01.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3528-4","article-title":"Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016","volume":"18","author":"Day","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.mimet.2019.01.001_bb0080","series-title":"European Committee on Antimicrobial Susceptibility Testing: Breakpoint Tables for Interpretation of MICs and Zone Diameters","author":"EUCAST","year":"2017"},{"key":"10.1016\/j.mimet.2019.01.001_bb0085","article-title":"Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018","volume":"23","author":"Eyre","year":"2018","journal-title":"Eur. Secur."},{"key":"10.1016\/j.mimet.2019.01.001_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02047-16","article-title":"In vitro activity of gepotidacin (GSK2140944) against Neisseria gonorrhoeae","volume":"61","author":"Farrell","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2019.01.001_bb0095","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of dual antimicrobial therapy in treatment of gonorrhea","volume":"374","author":"Fifer","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mimet.2019.01.001_bb0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.mimet.2013.10.007","article-title":"Comparison of Neisseria gonorrhoeae MICs obtained by Etest and agar dilution for ceftriaxone, cefpodoxime, cefixime and azithromycin","volume":"95","author":"Gose","year":"2013","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.mimet.2019.01.001_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility Surveillance \u2014 the Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014","volume":"65","author":"Kirkcaldy","year":"2016","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.mimet.2019.01.001_bb0125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3201\/eid2402.171756","article-title":"Ceftriaxone-resistant Neisseria Gonorrhoeae, Canada, 2017","volume":"24","author":"Lefebvre","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.mimet.2019.01.001_bb0130","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1128\/JCM.02131-13","article-title":"Assessment of Etest as an alternative to agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae","volume":"52","author":"Liu","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mimet.2019.01.001_bb0135","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jac\/dkx427","article-title":"MIC-based dose adjustment: Facts and fables","volume":"73","author":"Mouton","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2019.01.001_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-000969","article-title":"Comparative assessment of CDS, CLSI disc diffusion and Etest techniques for antimicrobial susceptibility testing of Neisseria gonorrhoeae: a 6-year study","volume":"2","author":"Singh","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.mimet.2019.01.001_bb0145","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1128\/JCM.43.9.4321-4327.2005","article-title":"Cultivation of Neisseria gonorrhoeae in liquid media and determination of its in vitro susceptibilities to quinolones","volume":"43","author":"Takei","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mimet.2019.01.001_bb0150","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug resistant drug resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2013","journal-title":"Future Microbiol"},{"key":"10.1016\/j.mimet.2019.01.001_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.EI10-0009-2015","article-title":"Antimicrobial resistance expressed by neisseria gonorrhoeae: a major global public health problem in the 21st Century","volume":"4","author":"Unemo","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.mimet.2019.01.001_bb0160","series-title":"STD Treatment Guidelines, 2015","first-page":"64","author":"Workowski","year":"2015"}],"container-title":["Journal of Microbiological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701218306614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701218306614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T23:58:11Z","timestamp":1759103891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167701218306614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":27,"alternative-id":["S0167701218306614"],"URL":"https:\/\/doi.org\/10.1016\/j.mimet.2019.01.001","relation":{},"ISSN":["0167-7012"],"issn-type":[{"value":"0167-7012","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Neisseria gonorrhoeae minimum inhibitory concentrations obtained using agar dilution versus microbroth dilution methods","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mimet.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}